Patient preferences for prenatal testing and termination of pregnancy for congenital anomalies and genetic diseases in Ethiopia

被引:10
|
作者
Brooks, Daniel [1 ]
Asta, Katharine [1 ]
Sturza, Julie [2 ]
Kebede, Birhanu [3 ]
Bekele, Delayehu [3 ]
Nigatu, Balkachew [3 ]
Hewison, Jenny [4 ]
Quinonez, Shane C. [5 ]
机构
[1] Univ Michigan, Sch Med, Ann Arbor, MI USA
[2] Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI USA
[3] St Pauls Hosp Millennium Med Coll, Dept Obstet & Gynecol, Addis Ababa, Ethiopia
[4] Univ Leeds, Leeds Inst Hlth Sci, Ctr Hlth Serv Res, Leeds, W Yorkshire, England
[5] Univ Michigan, Dept Pediat, Div Genet Metab & Genom Med, D5240 Med Profess Bldg,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA
关键词
SICKLE-CELL-DISEASE; AFRICA EXPERIENCE; FETAL-ABNORMALITY; MEDICAL GENETICS; DIAGNOSIS; ATTITUDES; CHILDREN; PARENTS; WOMEN; INTERVENTIONS;
D O I
10.1002/pd.5472
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
ObjectiveAs prenatal diagnostic services expand throughout low-income countries, an important consideration is the appropriateness of these services for patients. In these countries, services now include prenatal ultrasound and occasionally genetic testing. To assess patient interest, we surveyed pregnant patients at a hospital in Addis Ababa, Ethiopia, on their preferences for prenatal testing and termination of affected pregnancies for congenital anomalies and genetic diseases. MethodOne hundred one pregnant patients were surveyed on their preferences for prenatal testing and termination of affected pregnancies using a survey covering various congenital anomalies and genetic diseases. ResultsEighty-nine percent of patients reported interest in testing for all conditions. Three percent of patients were not interested in any testing. Over 60% of patients reported interest in termination for anencephaly, early infant death, severe intellectual disability, hemoglobinopathy, and amelia. Patients were more likely to express interest in prenatal testing and termination for conditions associated with a shortened lifespan. ConclusionEthiopian patients were interested in prenatal testing and termination of pregnancy for many conditions. Advancing prenatal diagnostic capacities is a potential strategy for addressing the incidence of congenital anomalies and genetic disease in Ethiopia. Importantly, there exist many factors and technological limitations to consider before implementation.
引用
收藏
页码:595 / 602
页数:8
相关论文
共 48 条
  • [41] Changing attitudes towards termination of pregnancy for trisomy 21 with non-invasive prenatal trisomy testing: a population-based study in Dutch pregnant women
    Verweij, E. J.
    Oepkes, Dick
    de Boer, Marjon A.
    PRENATAL DIAGNOSIS, 2013, 33 (04) : 397 - 399
  • [42] Vigilance in the Decision-Making Process Regarding Termination of Pregnancy Following Prenatal Diagnosis of Congenital Heart Disease-Application of the 'Conflict Decision-Making Model'
    Gendler, Yulia
    Birk, Einat
    Tabak, Nili
    Koton, Silvia
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (15)
  • [43] Decision-making on terminating pregnancy for Muslim Arab women pregnant with fetuses with congenital anomalies: maternal affect and doctor-patient communication
    Gesser-Edelsburg, Anat
    Shahbari, Nour Abed Elhadi
    REPRODUCTIVE HEALTH, 2017, 14
  • [44] Development and Pilot Testing of a Patient-Centered Reproductive Decision Aid for Pregnancy-Capable People With Rheumatic Diseases
    Birru Talabi, Mehret
    Clowse, Megan E. B.
    Abebe, Kaleab
    Blalock, Susan J.
    Callegari, Lisa S.
    Kazmerski, Traci M.
    O'Leary, Raelynn
    Deal, Ashley
    Wright, Catherine
    Pierce, Leslie E.
    Stransky, Olivia M.
    Lakkaraju, Goutham
    Jasti, Swetha
    Borrero, Sonya
    ACR OPEN RHEUMATOLOGY, 2025, 7 (03)
  • [45] Assessing the relationship between patient preferences for recontact after BRCA1 or BRCA2 genetic testing and their monitoring coping style in a Norwegian sample
    Ommundsen, Randi Marlene Dahle
    Stromsvik, Nina
    Hamang, Anniken
    JOURNAL OF GENETIC COUNSELING, 2022, 31 (02) : 554 - 564
  • [46] The impact of a second embryo biopsy for preimplantation genetic testing for monogenic diseases (PGT-M) with inconclusive results on pregnancy potential: results from a matched case-control study
    Guarneri, Cristina
    Reschini, Marco
    Pinna, Monica
    Perego, Lucia
    Sanzani, Elena
    Somigliana, Edgardo
    Sorrentino, Ugo
    Cassina, Matteo
    Zuccarello, Daniela
    Ciaffaglione, Marta
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2024, 41 (06) : 1605 - 1617
  • [47] First-trimester application of expanded non-invasive prenatal testing in the genetic investigation of fetal 22q11.2 deletion syndrome in a pregnancy conceived by in vitro fertilization and embryo transfer
    Chen, Chih-Ping
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2025, 64 (02): : 389 - 390
  • [48] In Vitro Fertilisation (IVF) Associated with Preimplantation Genetic Testing for Monogenic Diseases (PGT-M) in a Romanian Carrier Couple for Congenital Disorder of Glycosylation Type Ia (CDG-Ia): A Case Report
    Doroftei, Bogdan
    Nemtanu, Loredana
    Ilie, Ovidiu-Dumitru
    Simionescu, Gabriela
    Ivanov, Iuliu
    Anton, Emil
    Puiu, Maria
    Maftei, Radu
    GENES, 2020, 11 (06) : 1 - 11